The University of Texas MD Anderson Cancer Center
Houston, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Chronic myeloid leukaemia
Cure status
- asciminibPhase 3 · NCT05384587 · NCT06409936 · NCT04838041 · NCT06368414 · NCT04971226 · NCT06236724 · NCT05456191 · NCT06629584 · NCT07604233 · NCT03906292
- azacitidinePhase 3 · NCT04588922 · NCT00392353 · NCT03683433 · NCT06523556 · NCT06159491 · NCT04493138 · NCT03862157 · NCT07071155 · NCT04734990 · NCT06647862 · NCT05201066 · NCT04730258 · NCT01522976 · NCT03383575 · NCT04603001 · NCT05641259 · NCT04140487 · NCT06757855 · NCT04256317 · NCT03326310 · NCT07082452 · NCT03613532 · NCT05428969
- BosutinibPhase 3 · NCT04258943 · NCT06423911 · NCT03654768 · NCT04971226
- DasatinibPhase 3 · NCT07269470 · NCT02689440 · NCT07885293 · NCT04838041 · NCT05007873 · NCT00070499 · NCT07493408 · NCT04147533 · NCT03654768 · NCT04971226 · NCT03516279 · NCT03595917 · NCT03906292
- ELVN-001Phase 3 · NCT05304377 · NCT07905183 · NCT06787144
- Epoetin AlfaPhase 3 · NCT00843882
- FlumatinibPhase 3 · NCT07885293
- HS-10382Phase 3 · NCT07885293
- ImatinibPhase 3 · NCT07885293 · NCT04838041 · NCT03722420 · NCT07493408 · NCT03654768 · NCT04971226 · NCT07022743 · NCT04070443 · NCT03906292
- IMM01Phase 3 · NCT06647862
- LenalidomidePhase 3 · NCT01522976 · NCT00843882
- nilotinibPhase 3 · NCT02917720 · NCT07885293 · NCT06409936 · NCT04838041 · NCT07493408 · NCT04147533 · NCT03654768 · NCT04971226 · NCT03516279 · NCT05456191 · NCT03906292
- OlverembatinibPhase 3 · NCT06401603 · NCT06423911 · NCT06757855 · NCT06817720
- Oral decitabine/cedazuridinePhase 3 · NCT05883956
- RadotinibPhase 3 · NCT03722420
- Radotinib HClPhase 3 · NCT03459534
- Subcutaneous azacitidinePhase 3 · NCT05883956
- TGRX-678Phase 3 · NCT07489755 · NCT06453902 · NCT06088888 · NCT05434312
- TKIPhase 3 · NCT07489755 · NCT07905183
- treatment of TKI in CMLPhase 3 · NCT05753384
- venetoclaxPhase 3 · NCT04588922 · NCT02689440 · NCT02115295 · NCT04655755 · NCT03862157 · NCT05768711 · NCT04708054 · NCT04581512 · NCT05201066 · NCT05600894 · NCT04603001 · NCT03844048 · NCT04140487 · NCT06757855 · NCT05807932 · NCT04256317 · NCT07604233 · NCT07082452 · NCT03613532 · NCT05184842 · NCT05428969
- ASTX030 (cedazuridine + azacitidine)Phase 2/3 · NCT04256317
- BusulfanPhase 2/3 · NCT02727803 · NCT04708054 · NCT02861417 · NCT06001385 · NCT00544115 · NCT03613532 · NCT03779854 · NCT04904588
- CedazuridinePhase 2/3 · NCT04256317
- CladribinePhase 2/3 · NCT02115295 · NCT04708054 · NCT03589729 · NCT04375631
- Fludarabine PhosphatePhase 2/3 · NCT02727803 · NCT06904066 · NCT04708054 · NCT02861417 · NCT03670966 · NCT03128034 · NCT06013423 · NCT03192397 · NCT05092451 · NCT07582172 · NCT00544115
- ThiotepaPhase 2/3 · NCT04708054 · NCT02861417 · NCT05088356 · NCT02790515 · NCT03849651 · NCT03399773 · NCT06013423 · NCT03779854
- Abatacept (Orencia)Phase 2 · NCT07238712
- ABL001/AsciminibPhase 2 · NCT06514534
- Allogeneic CD34+-enriched and CD45RA-depleted PBSCsPhase 2 · NCT07819396
Closest to patients
- A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIsPhase 3 trial: Radotinib HClCI Cherkasy Regional Oncological Dispensary of CRC · Cherkassy, Ukraine + 16 more hospitalsPhase 3Results expected 2027
- Study of Olverembatinib (HQP1351) in Patients With CML-CPPhase 3 trial: olverembatinib, BosutinibPratia Onkologia Katowice · Katowice, Poland + 165 more hospitalsPhase 3Results expected 2027
- A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)Phase 2/3 trial: Azacitidine, ASTX030 (cedazuridine + azacitidine), CedazuridineHospital Universitario La Paz · Madrid, Spain + 73 more hospitalsPhase 2/3Results expected 2027
Choose one to continue
Larger text, shorter lines, fewer blocks, no animation.
Who are you looking for?
Your choice only changes the wording and the order on this page. It stays in this browser.
If you are looking for a relative
Here you will find questions you can ask, help with difficult talks, organisations for carers and your relative's rights.
Questions for your relative's doctor
How do I talk to them about this?
You do not need the right words. Ask what your relative wants to know, and let them set the pace. These pages can help.
Support for you as a carer
Looking after someone is work too. These organisations help carers, and the list further down this page shows helplines by country.
Power of attorney and patient rights, by country
A doctor can share information and a relative can act only with the patient's consent or a legal authority. It is easier to arrange this early.
- Hungary: patient rights representatives (Integrált Jogvédelmi Szolgálat)
- Germany: power of attorney and care directives (Federal Ministry of Justice)
- Austria: adult protection and representation (Ministry of Justice)
- United Kingdom: lasting power of attorney (GOV.UK)
- EU: your rights to healthcare in another EU country (Your Europe)
If you are looking for your child
Children are often treated differently from adults, in specialist centres. Here is where to start.
Before you pay
Parents often receive offers of paid treatment. Please go through this list before you pay for anything.
For patient organisations
You can share or print these pages for your members. They are free and need no account.
Apply for experimental treatment or a research study
The trial team decides who can take part; your doctor can help you ask.
Distance is calculated in your browser. Your city is not sent to us.
Loading trial sites…
Latest news
Results, new trials and publications, newest first. Every item links to its source.
Results and new studies, newest first, in plain words.
Plain-language summary pending. Original title shown.
New and changed trials of the last 30 days, without an account and without tracking.
RSS feedCalendar reminderPublication
Aptamers in cancer research: Focus on leukemia.
Aptamers in cancer research: Focus on leukemia.
Chinese medical journal
PubMed · PMID 42980187Publication
Capillary dried plasma microsampling: A novel approach for therapeutic drug monitoring of tyrosine kinase inhibitors in chronic myeloid leukemia patients by UPLC-MS/MS.
Capillary dried plasma microsampling: A novel approach for therapeutic drug monitoring of tyrosine kinase inhibitors in chronic myeloid leukemia patients by UPLC-MS/MS.
Journal of pharmaceutical and biomedical analysis
PubMed · PMID 42994209Case report
Prolonged indolent clinical course in a high-risk chronic phase-CML patient without cytogenetic or molecular response: a case challenging established response paradigms.
Prolonged indolent clinical course in a high-risk chronic phase-CML patient without cytogenetic or molecular response: a case challenging established response paradigms.
Annals of hematology
PubMed · PMID 42983022
Tools for your next step
Questions for your doctor
Pick up to 5 questions for your situation, then print them or take them on your phone.
Choose questionsOrganisations that can help
Helplines, patient groups and support services for you and your family.
Select your country to see the organisations there, starting with the ones closest to you.
Umbrella organisations (they connect national groups)
CML Advocates Network
Patient- and carer-led global network of CML patient groups: advocacy education, World CML Day, 'Know Your CML' app, CML Horizons conference, sharing of best practice.
Visit site: CML Advocates NetworkEuropean Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
Visit site: European Cancer Patient Coalition (ECPC)
EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
Visit site: EURORDIS – Rare Diseases Europe
Workgroup of European Cancer Patient Advocacy Networks
Network of pan-European cancer patient umbrella groups (including the blood cancer networks): joint advocacy, WECAN Academy training for patient advocates, patient experience data courses.
Visit site: Workgroup of European Cancer Patient Advocacy Networks
General support
For anyone who is ill, whatever the disease: patients' rights and legal aid, crisis lines, hospice and palliative care, care in another EU country, and patient organisations' umbrella bodies.
International
European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
Visit site: European Patients' Forum (EPF)
International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Visit site: International Alliance of Patients' Organizations
Frontlight is not affiliated with these organisations; we list them because they help.
Checked automatically every 90 days.
Find fellow researchers
Groups with active Chronic myeloid leukaemia work.
Princess Margaret Cancer Centre
Toronto, Canada
Team details appear once the team leader joins.
Is this your team? Claim it
Novartis (Switzerland)
Basel, Switzerland
Team details appear once the team leader joins.
Is this your team? Claim it
University of Toronto
Toronto, Canada
Team details appear once the team leader joins.
Is this your team? Claim it
University of Alabama at Birmingham
Birmingham, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Fred Hutch Cancer Center
Seattle, United States
Team details appear once the team leader joins.
Is this your team? Claim it
Sapienza University of Rome
Rome, Italy
Team details appear once the team leader joins.
Is this your team? Claim it
Institut Bergonié
Bordeaux, France
Team details appear once the team leader joins.
Is this your team? Claim it
Jena University Hospital
Jena, Germany
Team details appear once the team leader joins.
Is this your team? Claim it
Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, China
Team details appear once the team leader joins.
Is this your team? Claim it
Huazhong University of Science and Technology
Wuhan, China
Team details appear once the team leader joins.
Is this your team? Claim it
Institute of Hematology & Blood Diseases Hospital
Tianjin, China
Team details appear once the team leader joins.
Is this your team? Claim it